Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

Similar articles for PubMed (Select 24074190)

1.

Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.

Fareed A, Patil D, Scheinberg K, Blackinton Gale R, Vayalapalli S, Casarella J, Drexler K.

J Addict Dis. 2013;32(3):244-51. doi: 10.1080/10550887.2013.824333.

PMID:
24074190
2.

QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study.

Fareed A, Vayalapalli S, Scheinberg K, Gale R, Casarella J, Drexler K.

Am J Drug Alcohol Abuse. 2013 Jul;39(4):235-40. doi: 10.3109/00952990.2013.804525. Epub 2013 Jun 28.

PMID:
23808912
3.

Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.

Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H.

Addiction. 2009 Jun;104(6):993-9. doi: 10.1111/j.1360-0443.2009.02549.x. Epub 2009 Apr 9.

PMID:
19392907
4.

Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.

Stallvik M, Nordstrand B, Kristensen Ø, Bathen J, Skogvoll E, Spigset O.

Drug Alcohol Depend. 2013 Apr 1;129(1-2):88-93. doi: 10.1016/j.drugalcdep.2012.09.016. Epub 2012 Oct 16.

PMID:
23084592
5.

Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.

Peles E, Linzy S, Kreek MJ, Adelson M.

J Addict Med. 2013 Nov-Dec;7(6):428-34. doi: 10.1097/ADM.0b013e3182a8a4f2.

PMID:
24145160
6.

Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?

Mayet S, Gossop M, Lintzeris N, Markides V, Strang J.

Drug Alcohol Rev. 2011 Jul;30(4):388-96. doi: 10.1111/j.1465-3362.2010.00237.x. Epub 2010 Sep 6.

PMID:
21355918
7.

Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.

Roy AK, McCarthy C, Kiernan G, McGorrian C, Keenan E, Mahon NG, Sweeney B.

Addiction. 2012 Jun;107(6):1132-9. doi: 10.1111/j.1360-0443.2011.03767.x. Epub 2012 Feb 28.

PMID:
22168435
8.

Electrocardiogram characteristics of methadone and buprenorphine maintained subjects.

Athanasos P, Farquharson AL, Compton P, Psaltis P, Hay J.

J Addict Dis. 2008;27(3):31-5.

PMID:
18956527
9.

Onsite QTc interval screening for patients in methadone maintenance treatment.

Fareed A, Vayalapalli S, Byrd-Sellers J, Casarella J, Drexler K, Amar R, Smith-Cox J, Lutchman TS.

J Addict Dis. 2010 Jan;29(1):15-22. doi: 10.1080/10550880903436044.

PMID:
20390695
10.

Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.

Vallecillo G, Mojal S, Roquer A, Martinez D, Rossi P, Fonseca F, Muga R, Torrens M.

Clin Infect Dis. 2013 Oct;57(8):1189-94. doi: 10.1093/cid/cit467. Epub 2013 Jul 29.

11.

Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.

Chang KC, Huang CL, Liang HY, Chang SS, Wang YC, Liang WM, Lane HY, Chen CH, Stephen Huang SK.

J Cardiovasc Electrophysiol. 2012 May;23(5):527-33. doi: 10.1111/j.1540-8167.2011.02231.x. Epub 2011 Dec 2.

PMID:
22136144
12.

Prevalence of long QTc interval in methadone maintenance patients.

Fonseca F, Marti-Almor J, Pastor A, Cladellas M, Farré M, de la Torre R, Torrens M.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):327-32. doi: 10.1016/j.drugalcdep.2008.06.018. Epub 2008 Sep 5.

PMID:
18774239
13.

Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.

Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P.

Am J Epidemiol. 2014 Oct 1;180(7):673-86. doi: 10.1093/aje/kwu190. Epub 2014 Aug 22. Review.

PMID:
25150272
14.

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS.

Health Technol Assess. 2007 Mar;11(9):1-171, iii-iv. Review.

15.
16.

Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.

Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS.

Pharmacotherapy. 2003 Jun;23(6):802-5.

PMID:
12820821
17.

Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor.

Anchersen K, Hansteen V, Gossop M, Clausen T, Waal H.

Drug Alcohol Depend. 2010 Dec 1;112(3):216-9. doi: 10.1016/j.drugalcdep.2010.06.015. Epub 2010 Aug 10.

PMID:
20702049
18.

QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.

Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC.

Arch Intern Med. 2007 Dec 10;167(22):2469-75.

PMID:
18071169
19.

Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.

Ehret GB, Voide C, Gex-Fabry M, Chabert J, Shah D, Broers B, Piguet V, Musset T, Gaspoz JM, Perrier A, Dayer P, Desmeules JA.

Arch Intern Med. 2006 Jun 26;166(12):1280-7.

PMID:
16801510
20.

The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.

Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL, Bruera E.

J Palliat Med. 2010 Jan;13(1):33-8. doi: 10.1089/jpm.2009.0184.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk